Literature DB >> 12188318

Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1), a new intravascular contrast medium for MRI.

Friedrich M Cavagna1, Vito Lorusso, Pier Lucio Anelli, Fabio Maggioni, Christoph de Haën.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12188318     DOI： 10.1016/s1076-6332(03)80273-8

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  7 in total

1.  Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.

Authors:  Federico Boschi; Pasquina Marzola; Marco Sandri; Elena Nicolato; Mirco Galiè; Silvia Fiorini; Flavia Merigo; Vito Lorusso; Linda Chaabane; Andrea Sbarbati
Journal:  MAGMA       Date:  2008-03-04       Impact factor: 2.310

2.  A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors.

Authors:  Maddalena Arigoni; Giuseppina Barutello; Stefania Lanzardo; Dario Longo; Silvio Aime; Claudia Curcio; Manuela Iezzi; Yujuan Zheng; Irmeli Barkefors; Lars Holmgren; Federica Cavallo
Journal:  Angiogenesis       Date:  2012-03-17       Impact factor: 9.596

3.  Gd Complexes of DO3A-(Biphenyl-2,2'-bisamides) Conjugates as MRI Blood-Pool Contrast Agents.

Authors:  Ki-Hye Jung; Hee-Kyung Kim; Ji-Ae Park; Ki Soo Nam; Gang Ho Lee; Yongmin Chang; Tae-Jeong Kim
Journal:  ACS Med Chem Lett       Date:  2012-10-23       Impact factor: 4.345

4.  Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances.

Authors:  Hao Li; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2019-10-17       Impact factor: 15.419

Review 5.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

6.  B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.

Authors:  E Gianolio; C Cabella; S Colombo Serra; G Valbusa; F Arena; A Maiocchi; L Miragoli; F Tedoldi; F Uggeri; M Visigalli; P Bardini; S Aime
Journal:  J Biol Inorg Chem       Date:  2014-02-08       Impact factor: 3.358

7.  Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin.

Authors:  Virginie Henrotte; Luce Vander Elst; Sophie Laurent; Robert N Muller
Journal:  J Biol Inorg Chem       Date:  2007-06-09       Impact factor: 3.358
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.